By constructing Kaplan Meier survival curves, it was shown that increased NRP1 expression was correlated with poor overall, and disease-specific 5-year survival in patients with primary and metastatic melanoma, and was correlated with poorer overall, and disease-specific 10-year survival in all melanoma patients. This evidence concerns the gene NRP1 and metastatic melanoma.